Table 5.
Number of observations, participants, and estimated cases that we expect to include in the primary analyses.
| Analysis | Number of observations | Number of participants | Observations/Participants | Estimated number of casesa | Variance inflation factor |
| Cross-sectional | 11,670 | 7166 | 1.63 | 2334 | 1.31 |
| Prospective | 4746 | 3271 | 1.45 | 2610 | 1.05 |
aA case in the primary analysis will be defined as the shift from no use of antihypertensive drugs in examination n to use of antihypertensive drugs in examination n+1 or an above median delta value of systolic blood pressure (systolic blood pressure in examination n+1-systolic blood pressure in examination n).